1. Home
  2. PACB vs FINS Comparison

PACB vs FINS Comparison

Compare PACB & FINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacific Biosciences of California Inc.

PACB

Pacific Biosciences of California Inc.

SELL

Current Price

$2.10

Market Cap

521.8M

Sector

Industrials

ML Signal

SELL

Logo Angel Oak Financial Strategies Income Term Trust of Beneficial Interest

FINS

Angel Oak Financial Strategies Income Term Trust of Beneficial Interest

SELL

Current Price

$11.69

Market Cap

418.0M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
PACB
FINS
Founded
2000
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Finance/Investors Services
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
521.8M
418.0M
IPO Year
2010
2018

Fundamental Metrics

Financial Performance
Metric
PACB
FINS
Price
$2.10
$11.69
Analyst Decision
Buy
Analyst Count
8
0
Target Price
★ $2.40
N/A
AVG Volume (30 Days)
★ 15.4M
53.0K
Earning Date
11-04-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $93,468,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$16.01
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 3.04
N/A
52 Week Low
$1.07
$11.61
52 Week High
$3.44
$13.45

Technical Indicators

Market Signals
Indicator
PACB
FINS
Relative Strength Index (RSI) 55.33 35.26
Support Level $1.27 N/A
Resistance Level $2.73 $13.04
Average True Range (ATR) 0.28 0.18
MACD -0.04 -0.01
Stochastic Oscillator 23.92 15.00

Price Performance

Historical Comparison
PACB
FINS

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.

About FINS Angel Oak Financial Strategies Income Term Trust of Beneficial Interest

Angel Oak Financial Strats Income Term Trust is a non-diversified, closed-end management investment company. The fund's objective is to seek current income with a secondary objective of total return. In pursuing its investment objective, the fund invests mainly in debt issued by financial institutions, including subordinated debt, unrated debt, senior debt, and high-yield securities.

Share on Social Networks: